GENWORTH FINANCIAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GENWORTH FINANCIAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.30B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $7.30B | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | $1.91B | Feb 29, 2024 |
| FY2023 | Sep 30, 2023 | $1.83B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $1.89B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $1.85B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $1.87B | Feb 29, 2024 |
| FY2023 | Sep 30, 2022 | $1.85B | Feb 29, 2024 |
| FY2023 | Jun 30, 2022 | $1.89B | Feb 29, 2024 |
| FY2023 | Mar 31, 2022 | $1.89B | Feb 29, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $223.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $299.00M | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | ($212.00M) | Feb 29, 2024 |
| FY2023 | Sep 30, 2023 | $29.00M | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $137.00M | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $122.00M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $381.00M | Feb 29, 2024 |
| FY2023 | Sep 30, 2022 | $136.00M | Feb 29, 2024 |
| FY2023 | Jun 30, 2022 | $159.00M | Feb 29, 2024 |
| FY2023 | Mar 31, 2022 | $240.00M | Feb 29, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $41.00M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $818.00M | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $474.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $310.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $355.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | ($5.00M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $530.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($316.00M) | Feb 27, 2019 |
| FY2017 | Dec 31, 2015 | $255.00M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | ($398.00M) | Feb 27, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $977.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $942.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.29B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $998.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $935.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $909.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $943.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $957.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.27B | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $327.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $88.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $597.00M | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | $1.05B | Feb 28, 2023 |
| FY2022 | Dec 31, 2021 | $437.00M | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $1.96B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $2.08B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.63B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $2.55B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.87B | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.08B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $86.82B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $90.82B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $89.71B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $99.17B | Feb 28, 2023 |
| FY2023 | Jan 1, 2021 | $122.35B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $105.75B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $101.34B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $100.92B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $105.30B | Feb 27, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.32B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $77.44B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $82.48B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $81.33B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $82.91B | Feb 28, 2023 |
| FY2023 | Jan 1, 2021 | $120.27B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $89.93B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $86.71B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $86.73B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $89.97B | Feb 27, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.75B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.44B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.48B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $7.63B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $15.51B | Feb 28, 2023 |
| FY2023 | Jan 1, 2021 | $1.58B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $15.32B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $14.19B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $12.45B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $13.42B | Feb 27, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $14.00M | Feb 27, 2017 |
| FY2016 | Dec 31, 2015 | $14.00M | Feb 27, 2017 |
| FY2015 | Dec 31, 2014 | $16.00M | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $867.00M | Mar 2, 2015 |
| FY2014 | Dec 31, 2012 | $868.00M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $958.00M | Mar 3, 2014 |
| FY2012 | Dec 31, 2010 | $1.33B | Feb 28, 2013 |
| FY2011 | Dec 31, 2009 | $1.32B | Feb 27, 2012 |
| FY2010 | Dec 31, 2008 | $1.32B | Feb 25, 2011 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.68B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.46B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.21B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.14B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.49B | Feb 28, 2023 |
| FY2023 | Jan 1, 2021 | ($626.00M) | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $1.58B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.46B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.12B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.11B | Feb 27, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.03B | Feb 26, 2021 |
| FY2017 | Dec 31, 2017 | $2.88B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $2.78B | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $5.97B | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $4.65B | Feb 27, 2017 |
| FY2015 | Dec 31, 2013 | $3.66B | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $3.63B | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $4.44B | Mar 3, 2014 |
| FY2012 | Dec 31, 2010 | $3.13B | Feb 28, 2013 |
| FY2012 | Dec 31, 2009 | $5.00B | Feb 28, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.51B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.52B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.58B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.61B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.90B | Feb 28, 2023 |
| FY2023 | Jan 1, 2021 | $3.40B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $3.40B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $3.28B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $3.71B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.22B | Feb 27, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 29, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 29, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 29, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 391.84M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 421.42M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 446.82M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 495.45M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 508.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 506.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 504.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 501.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 499.00M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 498.00M | Feb 28, 2018 |